Seitz-Holland, Johanna http://orcid.org/0000-0002-1815-2681
Mulsant, Benoit H. http://orcid.org/0000-0002-0303-6450
Reynolds III, Charles F.
Blumberger, Daniel M.
Karp, Jordan F.
Butters, Meryl A.
Mendes-Silva, Ana Paula
Vieira, Erica L.
Tseng, George
Lenze, Eric J.
Diniz, Breno S. http://orcid.org/0000-0003-0653-1905
Funding for this research was provided by:
Harvard Medical School Livingston Fellowship Award Young Investigator Grant sponsored by Mary and John Osterhaus and the Brain & Behavior Research Foundation
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (P50MH122351, R01MH118311, R01 MH083660)
Taylor Family Institute for Innovative Psychiatric Research at Washington University
Article History
Received: 26 July 2022
Accepted: 10 February 2023
First Online: 22 March 2023
Competing interests
: E.J.L. is a consultant for Prodeo, IngenioRx, Pritikin ICR and Boehringer-Ingelheim, has a patent application for sigma-1 agonists in COVID-19 treatment and receives research support from PCORI, COVID Early Treatment Fund, Emergent Venture FastGrants and MagStim. J.F.K. reports receiving an honorarium from Otsuka for the preparation and presentation of a webinar (disease-state, not product focused), from NightWare and Biogen for scientific advising and potential equity from Aifred Health for scientific advising. B.H.M. holds and receives support from the Labatt Family Chair in Biology of Depression in Late-Life Adults at the University of Toronto. He also receives compensation from the Centre for Addiction and Mental Health (CAMH) and the University of Toronto, Ontario. He currently receives research support from Brain Canada, the Canadian Institutes of Health Research, the CAMH Foundation, the US National Institute of Health (NIH), Capital Solution Design LLC (software used in a study funded by CAMH Foundation) and HAPPYneuron (software used in a study funded by Brain Canada). Within the past 3 years, he has received research support from the Patient-Centered Outcomes Research Institute (PCORI), and he has been an unpaid consultant to Myriad Neuroscience. D.M.B. receives research support from CIHR, NIH, Brain Canada and the Temerty Family through the CAMH Foundation and the Campbell Research Institute. He received research support and in-kind equipment support for an investigator-initiated study from Brainsway Ltd. He has been the site principal investigator for sponsor-initiated studies for Brainsway Ltd. He also receives in-kind equipment support from Magventure for investigator-initiated studies. He received medication supplies for an investigator-initiated trial from Indivior. The other co-authors do not have a conflict of interest related to this study.